Plasma chitotriosidase activity in Gaucher disease patients who have been treated either by bone marrow transplantation or by enzyme replacement therapy with alglucerase
- 1 August 1997
- journal article
- clinical trial
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 20 (4) , 595-602
- https://doi.org/10.1023/a:1005367328003
Abstract
A marked elevation in plasma chitotriosidase (chitinase) activity has recently been observed in patients with Gaucher disease (Hollak et al 1994). It has been suggested that this phenomenon may serve...Keywords
This publication has 15 references indexed in Scilit:
- Marked increase of methylumbelliferyl-tetra-N-acetylchitotetraoside hydrolase activity in plasma from gaucher disease patientsJournal of Inherited Metabolic Disease, 1996
- Cloning of a cDNA Encoding Chitotriosidase, a Human Chitinase Produced by MacrophagesJournal of Biological Chemistry, 1995
- Individualised low-dose alglucerase therapy for type 1 Gaucher's diseaseThe Lancet, 1995
- TEN YEARS' EXPERIENCE OF BONE MARROW TRANSPLANTATION FOR GAUCHER DISEASETransplantation, 1995
- Purification and Characterization of Human Chitotriosidase, a Novel Member of the Chitinase Family of ProteinsJournal of Biological Chemistry, 1995
- Enzyme Therapy in Type 1 Gaucher Disease: Comparative Efficacy of Mannose-Terminated Glucocerebrosidase from Natural and Recombinant SourcesAnnals of Internal Medicine, 1995
- Low-dose enzyme replacement therapy for Gaucher's disease: Effects of age, sex, genotype, and clinical features on response to treatmentThe American Journal of Medicine, 1994
- Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.Journal of Clinical Investigation, 1994
- Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's DiseaseNew England Journal of Medicine, 1991
- BENEFICIAL EFFECT OF PRE-TRANSPLANT SPLENECTOMY ON DISPLACEMENT BONE MARROW TRANSPLANTATION FOR GAUCHER'S SYNDROMEThe Lancet, 1987